MAP7 Domain Containing 1 (MAP7D1) (N-Term) Peptide
MAP7D1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MAP7D1 products
- MAP7D1 (MAP7 Domain Containing 1 (MAP7D1))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MAP7D1 antibody (Catalog #: ARP57105_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MAP7D1 (MAP7 Domain Containing 1 (MAP7D1))
- Synonyms
- PARCC1 Peptide, RPRC1 Peptide, Mtap7d1 Peptide, AV028413 Peptide, BC019977 Peptide, Parcc1 Peptide, Rprc1 Peptide, mKIAA1187 Peptide, zgc:172238 Peptide, MAP7 domain containing 1 Peptide, MAP7 domain containing 1b Peptide, MAP7D1 Peptide, Map7d1 Peptide, map7d1b Peptide
- Background
-
The function of this protein remains unknown.
Alias Symbols: FLJ10350, FLJ39022, MGC117315, PARCC1, RPRC1
Protein Interaction Partner: APOA1,ATN1,C7orf64,COPS6,GPRASP1,APOA1,C7orf64,COPS6,GPRASP1,USP20
Protein Size: 841 - Molecular Weight
- 93 kDa
- Gene ID
- 55700
- NCBI Accession
- NM_018067, NP_060537
- UniProt
- Q3KQU3
-
You are here:
